Literature DB >> 11093477

Staged biventricular repair of pulmonary atresia or stenosis with intact ventricular septum.

S Sano1, K Ishino, M Kawada, E Fujisawa, M Kamada, S Ohtsuki.   

Abstract

BACKGROUND: Since 1991 we have performed a multistage palliative approach to biventricular repair of pulmonary atresia or critical pulmonary stenosis with intact ventricular septum in infants with a detectable right ventricular infundibulum.
METHODS: A total of 25 patients (19 pulmonary atresia and 6 critical pulmonary stenosis) underwent initial palliation consisting of a transarterial pulmonary valvotomy and a polytetrafluoroethylene shunt between the left subclavian artery and pulmonary trunk. Among the 23 survivors, 15 underwent balloon valvotomy. Six of these patients later required additional palliative surgery that consisted of repeat pulmonary valvotomy, adjustment of an atrial communication, and resection of the hypertrophied muscles in the right ventricle.
RESULTS: Of the 25 patients, 23 (92%) survived. In all, 20 patients underwent definitive operations: 18 (90%) biventricular repair (12 pulmonary atresia, and 6 critical pulmonary stenosis), one bidirectional Glenn, and one Fontan procedure. The actuarial probability of achieving a biventricular repair at 36 months of age was 69%. In 18 patients right ventricular end-diastolic volume significantly increased but tricuspid valve diameter did not change.
CONCLUSIONS: The multistage palliation procedure to promote right ventricular growth makes a definitive biventricular repair of pulmonary atresia or critical pulmonary stenosis with intact ventricular septum possible in the majority of infants with a patent infundibulum.

Entities:  

Mesh:

Year:  2000        PMID: 11093477     DOI: 10.1016/s0003-4975(00)01974-3

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  8 in total

1.  Hemodynamic assessment in patients with one-and-a-half ventricle repair revealed by four-dimensional flow magnetic resonance imaging.

Authors:  Sergio Uribe; Pablo Bächler; Israel Valverde; Gérard R Crelier; Philipp Beerbaum; Cristian Tejos; Pablo Irarrazaval
Journal:  Pediatr Cardiol       Date:  2012-03-25       Impact factor: 1.655

Review 2.  Biventricular repair versus uni-ventricular repair for pulmonary atresia with intact ventrical septum: A systematic review.

Authors:  Fei-Fei Li; Xin-Ling Du; Shu Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-10-22

3.  Exercise performance after surgery for pulmonary atresia and intact ventricular septum.

Authors:  Britt-Marie Ekman-Joelsson; Per M Gustafsson; Jan Sunnegårdh
Journal:  Pediatr Cardiol       Date:  2009-04-14       Impact factor: 1.655

4.  Evolution of the management approach for pulmonary atresia with intact ventricular septum.

Authors:  Y P Mi; A K T Chau; C S W Chiu; T C Yung; K S Lun; Y F Cheung
Journal:  Heart       Date:  2005-05       Impact factor: 5.994

Review 5.  Surgical strategy for pulmonary atresia with intact ventricular septum: initial management and definitive surgery.

Authors:  Naoki Yoshimura; Masahiro Yamaguchi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2009-07-14

6.  Feasibility, safety, and efficacy of iron bioresorbable scaffold in neonates with duct-dependent pulmonary circulation.

Authors:  Marhisham Che Mood; Khalil Ahmad Niazy; Mazeni Alwi; Hasri Samion; Koh Ghee Tiong; Sivakumar Sivalingam; Deyuan Zhang
Journal:  Ann Pediatr Cardiol       Date:  2022-08-19

7.  Outcome Predictors in Catheter Interventions for Severe Right Ventricular Outflow Tract Obstructions.

Authors:  Sonia A El-Saiedi; Wael A Attia; Ashraf Abd El-Rahim; Baher M Hanna
Journal:  J Saudi Heart Assoc       Date:  2022-04-11

8.  Differences in Right Ventricular Physiologic Response to Chronic Volume Load in Patients with Repaired Pulmonary Atresia Intact Ventricular Septum/Critical Pulmonary Stenosis Versus Tetralogy of Fallot.

Authors:  Andrew L Cheng; Abraham M Kaslow; Jay D Pruetz; Jimmy C Lu; John C Wood; Jon A Detterich
Journal:  Pediatr Cardiol       Date:  2018-10-23       Impact factor: 1.655

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.